BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis

被引:136
作者
Pauli-Magnus, C
Kerb, R
Fattinger, K
Lang, T
Anwald, B
Kullak-Ublick, GA
Beuers, U
Meier, PJ
机构
[1] Univ Zurich Hosp, Div Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland
[2] Epidauros Biotechnol AG, Bernried, Germany
[3] Univ Zurich, Univ Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland
[4] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany
关键词
D O I
10.1002/hep.20159
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are characterized by a cholestatic pattern of liver damage, also observed in hereditary or acquired dysfunction of the canalicular membrane transporters bile salt export pump (BSEP, ABCB11) and multidrug resistance protein type 3 (MDR3, ABCB4). Controversy exists whether a genetically determined dysfunction of BSEP and MDR3 plays a pathogenic role in PBC and PSC. Therefore, 149 healthy Caucasian control individuals (control group) were compared to 76 PBC and 46 PSC patients with respect to genetic variations in BSEP and MDR3. Sequencing spanned similar to10,000 bp including promoter and coding regions as well as 50-350 bp of flanking intronic regions. In all, 46 and 45 variants were identified in BSEP and MDR3, respectively. No differences between the groups were detected either in the total number of variants (BSEP: control group: 37, PBC: 37, PSC: 31; and MDR3: control group: 35; PBC: 32, PSC: 30), or in the allele frequency of the common variable sites. Furthermore, there were no significant differences in haplotype distribution and linkage disequilibrium. In conclusion, this study provides an analysis of BSEP and MDR3 variant segregation and haplotype structure in a Caucasian population. Although an impact of rare variants on BSEP and MDR3 function cannot be ruled out, our data do not support a strong role of BSEP and MDR3 genetic variations in the pathogenesis of PBC and PSC.
引用
收藏
页码:779 / 791
页数:13
相关论文
共 32 条
[1]   Primary sclerosing cholangitis [J].
Angulo, P ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (01) :325-332
[2]   FAMILIAL PRIMARY BILIARY-CIRRHOSIS [J].
BACH, N ;
SCHAFFNER, F .
JOURNAL OF HEPATOLOGY, 1994, 20 (06) :698-701
[3]   Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis [J].
De Vree, JML ;
Jacquemin, E ;
Sturm, E ;
Cresteil, D ;
Bosma, PJ ;
Aten, J ;
Deleuze, JF ;
Desrochers, M ;
Burdelski, M ;
Bernard, O ;
Elferink, RPJO ;
Hadchouel, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :282-287
[4]  
DEWIT AWMV, 1995, AM J GASTROENTEROL, V90, P893
[5]   Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles [J].
Fickert, P ;
Zollner, G ;
Fuchsbichler, A ;
Stumptner, C ;
Weiglein, AH ;
Lammert, F ;
Marschall, HU ;
Tsybrovskyy, O ;
Zatloukal, K ;
Denk, H ;
Trauner, M .
GASTROENTEROLOGY, 2002, 123 (04) :1238-1251
[6]   Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis:: Is Propionibacterium acnes involved in granuloma formation? [J].
Harada, K ;
Tsuneyama, K ;
Sudo, Y ;
Masuda, S ;
Nakanuma, Y .
HEPATOLOGY, 2001, 33 (03) :530-536
[7]   Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy [J].
Jacquemin, E ;
Cresteil, D ;
Manouvrier, S ;
Boute, O ;
Hadchouel, M .
LANCET, 1999, 353 (9148) :210-211
[8]   The wide spectrum of multidrug resistance 3 deficiency: From neonatal cholestasis to cirrhosis of adulthood [J].
Jacquemin, E ;
de Vree, JML ;
Cresteil, D ;
Sokal, EM ;
Sturm, E ;
Dumont, M ;
Scheffer, GL ;
Paul, M ;
Burdelski, M ;
Bosma, PJ ;
Bernard, O ;
Hadchouel, M ;
Elferink, RPJO .
GASTROENTEROLOGY, 2001, 120 (06) :1448-1458
[9]  
Judson R, 2000, Pharmacogenomics, V1, P15, DOI 10.1517/14622416.1.1.15
[10]   Medical progress - Primary biliary cirrhosis [J].
Kaplan, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (21) :1570-1580